Compounds > salicylanilide
Page last updated: 2024-08-17

salicylanilide and Tuberculosis, Drug-Resistant

salicylanilide has been researched along with Tuberculosis, Drug-Resistant in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baranyai, Z; Bősze, S; Dávid, S; Krátký, M; Senoner, Z; Stolaříková, J; Szabó, E; Vinšová, J; Vosátka, R1
Baranyai, Z; Bősze, S; Dávid, S; Horváti, K; Krátký, M; Senoner, Z; Stolaříková, J; Szabó, N; Vinšová, J1
Krátký, M; Monteiro, S; Navrátilová, L; Paraskevopoulos, G; Stolaříková, J; Trejtnar, F; Vinšová, J; Vosátka, R1
Bhat, S; Fernandes, S; Krátký, M; Liu, JO; Mandíková, J; Novotná, E; Stolaříková, J; Trejtnar, F; Ulmann, V; Vinšová, J; Wsól, V1

Other Studies

4 other study(ies) available for salicylanilide and Tuberculosis, Drug-Resistant

ArticleYear
In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates.
    European journal of medicinal chemistry, 2017, Jun-16, Volume: 133

    Topics: Animals; Antitubercular Agents; Cell Line; Humans; Mycobacterium; Mycobacterium Infections; Mycobacterium tuberculosis; Rats; Salicylanilides; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuftsin

2017
Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
    European journal of medicinal chemistry, 2015, Aug-28, Volume: 101

    Topics: Anti-Bacterial Agents; Carbamates; Cell Line; Dose-Response Relationship, Drug; Esters; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Salicylanilides; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant

2015
Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
    Bioorganic & medicinal chemistry, 2017, 02-15, Volume: 25, Issue:4

    Topics: Antitubercular Agents; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Salicylanilides; Salicylates; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant

2017
Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase.
    Tuberculosis (Edinburgh, Scotland), 2012, Volume: 92, Issue:5

    Topics: Antitubercular Agents; Czech Republic; Dose-Response Relationship, Drug; Female; Humans; Isocitrate Lyase; Male; Methionyl Aminopeptidases; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Salicylanilides; Socioeconomic Factors; Tuberculosis, Multidrug-Resistant

2012